Early use of hypertonic fluids does not appear to improve outcomes for severe traumatic brain injury
2010-10-06
(Press-News.org) Patients with a severe traumatic brain injury (and not in shock because of blood loss) who received out-of-hospital administration of hypertonic fluids (a solution with increased concentration of certain electrolytes and thought to help reduce intracranial pressure) as initial resuscitation did not experience better 6-month neurologic outcomes or survival compared to patients who received a normal saline solution, according to a study in the October 6 issue of JAMA.
Traumatic brain injury (TBI) is the leading cause of death following blunt trauma, and survivors often sustain severe disability. The primary injury to the brain occurs at the time of impact; however, subsequent decreased cerebral blood flow can lead to a secondary brain injury. "Current therapy following severe TBI is focused on minimizing secondary injury by supporting systemic perfusion [blood flow] and reducing intracranial pressure (ICP). Intravenous fluid resuscitation currently begins in the out-of-hospital setting; however, therapy for management of cerebral edema [swelling] is often delayed until after hospital arrival," the authors write.
Hypertonic fluids, which can restore cerebral perfusion with reduced cerebral edema, have the potential to be of benefit in resuscitation of patients with severe TBI. "Previous trials have suggested that early administration of hypertonic fluids to patients with severe TBI may improve survival, but no large definitive trials have been reported and the effects on neurologic outcome are not known," the researchers write.
Eileen M. Bulger, M.D., of UW Medicine's Harborview Medical Center, Seattle, and colleagues conducted a study to examine whether administration of hypertonic fluids as early as possible after severe TBI in patients without hemorrhagic shock would result in improved 6-month neurologic outcomes. The randomized, placebo-controlled clinical trial involved 114 North American emergency medical services agencies within the Resuscitation Outcomes Consortium. The study was conducted between May 2006 and May 2009 among patients 15 years or older with blunt trauma and a certain prehospital Glasgow Coma Scale score (a system used to assess the degree of brain impairment) who did not meet criteria for shock from blood loss (hypovolemia). Patients received either hypertonic saline/dextran (a water-soluble polymer of glucose), hypertonic saline, or normal saline, initiated in the out-of-hospital setting. After six months, neurologic outcome was measured with the Extended Glasgow Outcome Scale (GOSE; a scale that assesses the outcome of serious brain injuries).
There were no significant differences in characteristics of the patients at the beginning of the study, injury severity scores, and out-of-hospital care provided between treatment groups. Of the patients in the study, complete 6-month neurologic outcome data were available for 1,087 of 1,282 treated patients (85 percent). The researchers found that there was no difference in 6-month neurologic outcome among groups with regard to proportions of patients with severe TBI (GOSE score of 4 or less: severe disability, vegetative state, or death): hypertonic saline/dextran vs. normal saline: 53.7 percent vs. 51.5 percent; hypertonic saline vs. normal saline: 54.3 percent vs. 51.5 percent. "There were no statistically significant differences in distribution of GOSE category or Disability Rating Score by treatment group. Survival at 28 days was 74.3 percent with hypertonic saline/dextran, 75.7 percent with hypertonic saline, and 75.1 percent with normal saline," the authors write.
"In summary, in this randomized controlled trial, we were unable to demonstrate any improvement in 6-month neurologic outcome or survival for trauma patients with presumed severe TBI without evidence of hypovolemic shock, who received a single bolus [large dose] of hypertonic fluids compared with normal saline in the out-of-hospital setting. While this does not preclude a benefit from such treatment were it administered differently, at present there appears to be no compelling reason to adopt a practice of hypertonic fluid resuscitation for TBI in the out-of-hospital setting."
###
(JAMA. 2010;304[13]:1455-1464. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-10-06
Giving vitamin D supplements to healthy children with normal vitamin D levels does not improve bone density at the hip, lumbar spine, forearm or in the body as a whole, according to a new Cochrane Systematic Review.
Building bone density in children helps protect against osteoporosis in later life. Osteoporosis is a condition where bones are weak, brittle and break easily. Vitamin D helps the body absorb calcium from food, reduces losses of calcium from the body and encourages calcium deposition into bone. Bone density is a major measure of bone strength and measures ...
2010-10-06
When compared with placebo and other drugs, long-term use of finasteride improves urinary tract symptoms associated with benign prostatic hyperplasia, and reduces disease progression. This conclusion comes from combining the findings of 23 randomized clinical trials that evaluated almost 21,000 men, and is published this month in The Cochrane Library.
Finasteride is frequently given to men who have lower urinary tract symptoms (LUTS) such as frequent voiding at night (nocturia), incomplete emptying, hesitancy, weak stream, and frequent and urgent urination. The symptoms ...
2010-10-06
There is no evidence that increasing the dose of inhaled corticosteroids at the onset of an asthma exacerbation, as part of a patient-initiated action plan, reduces the need for rescue oral corticosteroids. This is the conclusion of work published in The Cochrane Library this month.
There are two mechanisms acting in the lungs of people with asthma. The first is called bronchoconstriction, which is when people's airways constrict during an asthma attack, making it much harder for them to move air in and out of their lungs. The first line treatment for this sort of acute ...
2010-10-06
Diabetes is the leading reason for kidney failure in the world, resulting in patients requiring dialysis or kidney transplantation. New research has found a cell in the kidney called the podocyte could be the key to understanding why this happens.
The study led by Dr Richard Coward, in the School of Clinical Sciences at the University of Bristol, is published in Cell Metabolism and funded by the Medical Research Council (MRC).
Diabetes related kidney disease has previously been thought to be mainly due to the high levels of sugar in the blood damaging the small blood ...
2010-10-06
Kyoto, Japan -- Knowing how to build nanosized assemblies of polymers (long molecular chains) holds the key to improving a broad range of industrial processes, from the production of nanofibers, filters, and new materials to the manufacture of low-energy, nanoscale circuits and devices. A recent paper in Nature Communications sheds light on key behaviors of polymers in specially engineered confined spaces, opening the door to a level of control that has previously been impossible.
Scientists in Japan at Kyoto University and Nagoya University have succeeded in manufacturing ...
2010-10-06
Members of the European Parliament are calling on the Presidency of the EU and Member States to tackle urgently the problem of chronic non-communicable diseases that are responsible for 86% of all deaths in the WHO European Region. Their call is supported by an alliance of European health professionals, including ECCO – the European CanCer Organisation – and ESMO – the European Society for Medical Oncology.
After a meeting later today (Tuesday) between MEPs and the Chronic Disease Alliance of ten not-for-profit European organisations that represent over 100,000 health ...
2010-10-06
The Government's ability to intervene directly to protect people's health and well-being has reached its limits in modern society because the health issues of today are closely tied in with individual lifestyle choice and freedoms, a leading academic will say today (October 5).
Public health issues have previously been more amenable to government intervention and included improving sanitation or air quality, or controlling infectious disease. But public health issues today, like smoking, drink and diet, have meant that legislation is a blunt instrument in tackling these ...
2010-10-06
Washington, D.C. (October 5, 2010) -- A prototype device developed in Hong Kong will allow laboratory researchers to non-invasively test drugs for their ability to kill tumors by subjecting cancerous cells with different concentration gradients. The new device is built upon microfluidics -- a set of technologies that allows the control and manipulation of fluids at the sub-millimeter scale -- and is described in the American Institute of Physics' journal Biomicrofluidics.
Microfluidic valves within the device, said Hongkai Wu of Hong Kong University of Science and Technology, ...
2010-10-06
Washington, D.C. (October 5, 2010) -- The explosion of portable communication devices that we enjoy today -- such as cell and smart phones, Bluetooth hands-free units, and wireless Internet networks -- has resulted in part from the development of a wide variety of integrated circuits that create, process and receive the microwave frequencies on which the communication is based.
Continuing demand for higher performance over a wider range of frequencies has shrunk the physical size of circuits and fueled the development of new materials in thin-film forms, tested in detail ...
2010-10-06
Washington, D.C. (October 5, 2010) -- Protein molecules inside cells are constantly reorganizing themselves, driven by very tiny forces exerted by all the other molecules in their crowded environment. Most experimental techniques and theoretical/computational models are necessarily built around much greater driving forces. A new theoretical model reported in the Journal of Chemical Physics investigates the unfolding of fibronectin under gentler conditions.
"Typical models study very fast processes and consume a lot of CPU time," says author Alessandro Pelizzola of the ...
LAST 30 PRESS RELEASES:
[Press-News.org] Early use of hypertonic fluids does not appear to improve outcomes for severe traumatic brain injury